NephroNet

Name

NephroNet

Legal name

Nephronet, Inc.

Website

https://nephronet.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Clinical Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

Keywords

• Nephrology clinical research
• Clinical research organization
• Site feasibility services
• Subject identification referrals
• Investigator network services

Headquarters

HQ city

Lawrenceville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. CRO Services - Full-Service Clinical Research: NephroNet generates revenue by providing comprehensive clinical research organization services to pharmaceutical and biotech sponsors conducting nephrology trials. Services include study feasibility and site selection, project management, clinical monitoring, subject identification and referrals, and KOL consulting. Revenue is project-based, likely structured as service contracts or milestone-based billing.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

NephroNet is a full-service clinical research organization (CRO) exclusively focused on nephrology, providing pharmaceutical and biotech sponsors with study feasibility, site selection and activation across 400+ nephrology research sites, project management, clinical monitoring, key opinion leader (KOL) consulting, and subject identification and referrals. The company pairs this site and investigator network with a partnership-based biopsy-proven subject identification workflow to support end-to-end renal disease clinical trials.

Product overview

NephroNet is a full-service clinical research organization (CRO) exclusively focused on nephrology, founded in 2010. The company offers a unified platform of integrated services including site feasibility and activation (accessing 400+ nephrology research sites), subject identification through a partnership with Arkana Laboratories, KOL renal consulting, investigator network recruitment, and full project management and clinical monitoring. The core offering is the Full-Service Nephrology CRO, supported by complementary service modules that together provide end-to-end clinical trial support for renal disease studies. A patient hotline (1-800-881-0314) provides direct enrollment inquiry support.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Over 400 nephrology-focused sites available for trial activation
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Arkana LaboratoriescoreStrategic or Co-development PartnerNephroNet has partnered with Arkana Laboratories to identify patients after a biopsy-proven diagnosis. Following a HIPAA-compliant process, identified subjects are referred to the closest trial site for enrollment. The entire process is tracked with metrics provided to sponsors. This partnership enables NephroNet to provide patients with study referral options for numerous nephrology trials.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• DaVita Clinical Research: The clinical research arm of DaVita, the largest U.S. dialysis provider. DCR runs nephrology and renal-disease clinical trials and is the most direct competitor to NephroNet's specialty nephrology CRO offering, sharing the same sponsor base and investigator network orientation.
• Frenova Renal Research: A nephrology-focused clinical research organization built around a large network of renal investigators and dialysis patients. Frenova is the closest head-to-head peer to NephroNet, both in therapeutic-area focus and in business model (specialty CRO with site network).
• CTI Clinical Trial and Consulting Services: A specialty CRO focused on rare and serious diseases including renal and metabolic indications. Comparable to NephroNet in being a mid-size, therapeutically specialized CRO serving pharma/biotech sponsors with full-service trial capabilities.

Broad incumbents

• Medpace: A mid-to-large full-service CRO with a strong therapeutic-specialization model (cardiovascular, renal, metabolic among others). Comparable to NephroNet in its therapeutic-focus sales motion, but operates at significantly greater scale and global reach.
• Premier Research: A specialty-focused CRO with deep expertise in nephrology, rare disease, and other complex therapeutic areas. Directly comparable to NephroNet in nephrology trial capabilities and sponsor target market, but operates globally with broader service breadth.
• Worldwide Clinical Trials: A mid-size global CRO with strong neuroscience, cardiovascular, and metabolic therapeutic-area practices. Comparable to NephroNet as a therapeutically specialized mid-market CRO targeting the same pharma/biotech sponsor buyer.
• IQVIA: The largest global CRO and life sciences services company. IQVIA competes with NephroNet for the same nephrology trial RFPs from pharma sponsors, although it operates as a full-service generalist with much broader scale and proprietary data/technology assets.
• ICON plc: A top-tier global CRO with comprehensive therapeutic-area coverage including renal studies. Comparable to NephroNet as a full-service CRO serving large pharma sponsors, but at materially greater scale and broader geographic reach.
• Syneos Health: A global biopharma solutions organization offering CRO and commercialization services. Overlaps with NephroNet on the CRO side for nephrology and adjacent therapeutic-area trials, but at far greater scale and as a publicly traded incumbent.

Others

• WCG Clinical: A clinical trial solutions provider focused on site activation, IRB review, and trial technology. Comparable to NephroNet as an enabling partner to the same investigator sites and sponsors, but positioned as an ecosystem/infrastructure provider rather than a competing CRO.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NephroNet